Company intelligence / Profile preview

Aldatu Biosciences

Watertown, Massachusetts, United Statesaldatubio.com ↗

Ownership: Private
Employees: ~20
Development stage: Commercial

Overview

Aldatu Biosciences has developed and commercialized advanced PCR-based molecular diagnostic assays for infectious diseases, with a focus on rapid, affordable detection of pathogens such as HIV, CCHFV, Lassa fever virus, and others. Their proprietary PANDAA™ platform enables high-throughput genotyping and pathogen detection. The company has received significant NIH funding to expand its universal viral detection capabilities.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic assayPCR-based diagnosticsMolecular diagnostic assay
Industry: Molecular Diagnostics

Partnerships

NIH/NIAID grant funding partnership for R&D advancement. No major pharma partnerships disclosed.

Beyond the preview

Go deeper on Aldatu Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aldatu Biosciences.

Explore the full profile